Form 8-K - Current report:
SEC Accession No. 0001493152-24-034647
Filing Date
2024-08-30
Accepted
2024-08-30 17:25:53
Documents
13
Period of Report
2024-08-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36796
  Complete submission text file 0001493152-24-034647.txt   206253

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ppcb-20240826.xsd EX-101.SCH 3012
3 XBRL LABEL FILE ppcb-20240826_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ppcb-20240826_pre.xml EX-101.PRE 24163
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3334
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 241271206
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)